Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
gMFA4C8j1kMHXyRq
